Molecules Making a Difference

As the world continues to fight the COVID-19 pandemic, more than ever, we are reminded of the crucial need to invest in research and development for affordable medicines. Medicines for Malaria Venture was created at a time when the antimalarial pipeline was virtually empty, and malaria was killing over 1 million people every year. Ever since this time, MMV's scientists, physicians and partners have worked tirelessly to build the largest portfolio of medicines for malaria in history.

This year, Medicines for Malaria Venture has collaborated with artist Steph Fonteyn to celebrate the molecules that have become lifesaving medicines and are helping to accelerate efforts to end malaria for good.